Afterlife and Immortality in the Death Discourse
Sober Search · 13.07.2025 · 1 (1) · 11-20
DOI: 10.70118/ssjp0002 ↗Kurz gefasst
Fachartikel in der Zeitschrift Sober Search, online erschienen am 13.07.2025. Verfasst von Moses Akinnade Jawo.
Abstract (Originalsprache)
This paper examines the concepts of the afterlife and immortality – two similar terms yet with differences and often used interchangeably. They are crucial in the discourse on death and virtually all scholars centre their discourse on their existence or otherwise. Religion is the proponent of immortality; its arguments were rejected by science for lack of empirical verifiability. Recent scientific research focuses on how humans live immortally and possibly revive the dead. This aligns with religious immortality and contradicts science’s understanding of human biology. The debates about life after death are on two polarities: religious and scientific and each has internal inconsistencies. This paper uses the qualitative research method of conceptual clarifications and critical analysis to interrogate the arguments of the two polarities. It realises their inconsistencies are because death is unknowable with humans’ present cognitive apparatus, so postulations about life after death are confusing. Therefore, it submits that humans should live within their lifespans for the betterment of humanity. Life after death could be a privilege but should not be the major driving force for doing good. Life is meaningful when well lived, and death is just a natural phenomenon.
Zitieren
APA
Jawo, M. A. (2025). Afterlife and Immortality in the Death Discourse. Sober Search, 1(1), 11-20. https://doi.org/10.70118/ssjp0002
Vancouver
Jawo MA. Afterlife and Immortality in the Death Discourse. Sober Search. 2025;1(1):11-20. doi:10.70118/ssjp0002
BibTeX
@article{Jawo2025,
author = {Jawo, Moses Akinnade},
title = {Afterlife and Immortality in the Death Discourse},
journal = {Sober Search},
year = {2025},
volume = {1},
number = {1},
pages = {11--20},
doi = {10.70118/ssjp0002}
}
EUVIMED